Emerging molecular technologies for identifying the risk of second cancers

Cancer Prevention Research

Volumn 2, Issue 7, 2009, Pages 605-607

  Mayne, Susan T ^a,c   Gruber, Stephen B ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; BETA CAROTENE; ISOTRETINOIN; PLACEBO; RETINOID;

CANCER PREVENTION; CANCER RECURRENCE; CANCER RISK; CLINICAL TRIAL; DRUG EFFICACY; ENVIRONMENTAL FACTOR; GENETIC RISK; GENOME ANALYSIS; GENOTYPE; HEAD AND NECK CARCINOMA; HUMAN; LIFESTYLE; LOW DRUG DOSE; PRIORITY JOURNAL; PROSTATE CANCER; RISK ASSESSMENT; SECOND CANCER; SHORT SURVEY; SINGLE NUCLEOTIDE POLYMORPHISM; SQUAMOUS CELL CARCINOMA;

ANTICARCINOGENIC AGENTS; DNA, MITOCHONDRIAL; GENETIC PREDISPOSITION TO DISEASE; GENETIC TECHNIQUES; HUMANS; MASS SCREENING; MEDICAL ONCOLOGY; NEOPLASMS, SECOND PRIMARY; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; RISK ASSESSMENT;

EID: 69249162702     PISSN: 19406207     EISSN: None     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-09-0101     Document Type: Short Survey

References (15)

1. Travis LB, Rabkin CS, Brown LM, et al. Cancer survivorship-genetic susceptibility and second primary cancers: research strategies and recommendations. J Natl Cancer Inst 2006;98:15-25.
2. Wu X, Spitz MR, Lee JJ, et al. Novel susceptibility loci for second primary tumors/recurrence in head and neck cancer patients: large scale evaluation of genetic variants. Cancer Prev Res. In press.
3. Gleich LL, Salamone FN. Molecular genetics of head and neck cancer. Cancer Control 2002;9:369-378 (Pubitemid 35204459)
4. Khuri FR, Kim ES, Lee JJ, et al. The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial. Cancer Epidemiol Biomarkers Prev 2001;10:823-829
5. Mayne ST, Giovannucci E, Lippman SM. Cancer prevention: chemoprevention. Retinoids, carotenoids, and other micronutrients in cancer prevention. In: DeVita VT, Jr., Lawrence TS, Rosenberg SA, editors. Philadelphia: Lippincott Williams & Wilkins; 2008, p. 615-625
6. Khuri FR, Lee JJ, Lippman SM, et al. Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients. J Natl Cancer Inst 2006;98:441-450
7. Song K, Elston RC. A powerful method of combining measures of association and Hardy-Weinberg disequilibrium for fine-mapping in case-control studies. Stat Med 2006;25:105-126 (Pubitemid 43136952)
8. Joo J, Kwak M, Zheng G. Improving power for testing genetic association in case-control studies by reducing the alternative space. Biometrics, published on-line April 13, 2009.
9. Zheng SL, Sun J, Wiklund F, et al. Cumulative association of five genetic variants with prostate cancer. N Engl J Med 2008;358:910-919
10. Gail MH. Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk [see comment]. J Natl Cancer Inst 2008;100:1037-1041
11. Spitz MR, Hong WK, Amos CI, et al. A risk model for prediction of lung cancer. J Natl Cancer Inst 2007;99:715-726 (Pubitemid 47073532)
12. Spitz MR, Etzel CJ, Dong Q, et al. An expanded risk prediction model for lung cancer [see comment]. Cancer Prev Res 2008;1:250-254
13. Bolla M, Lefur R, Ton Van J, et al. Prevention of second primary tumours with etretinate in squamous cell carcinoma of the oral cavity and oropharynx. Results of a multicentric double-blind randomised study. Eur J Cancer 1994;30A:767-772 (Pubitemid 24217331)
14. van Zandwijk N, Dalesio O, Pastorino U, de Vries N, van Tinteren H. EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. For the European Organization for Research and Treatment of Cancer Head and Neck and Lung Cancer Cooperative Groups. J Natl Cancer Inst 2000;92:977-986
15. Hung RJ, van der Hel O, Tavtigian SV, et al. Perspectives on the molecular epidemiology of aerodigestive tract cancers. Mutat Res 2005;592:102-118